Celecoxib increased expression of 14-3-3σ and induced apoptosis of glioma cells

Jin Cherng Chen, Yun Chen, Yen Hao Su, Sheng Hong Tseng

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Celecoxib, a cyclooxygenase-2 inhibitor, has been found to inhibit the proliferation of several kinds of cancer cells; however, the effects of celecoxib on glioma cells are not clear. Materials and Methods: A172 glioma cells were treated with various concentrations of celecoxib for 4, 24 or 48 h. Cytotoxic drug effects were studied by MTT (3-[4,5-dimethylthiazole-2-yl]-2,5- diphenyltetrazolium bromide)-based colorimetric assay, and celecoxib-induced apoptosis of glioma cells was investigated by FACScan. Western blot analysis was used to study celecoxib effects on the expression of mitogen-activated protein kinases (MAPKs), p53, p21, 14-3-4σ, Bcl-2 and Box. Caspace-3 activity in glioma cells was analyzed by caspase activity assay. Results: Celecoxib exerted cytotoxic effects upon and induced apoptosis of the A172 glioma cells in a concentration and time-dependent manner (p<0.05). Celecoxib had no effects on expression of MAPKs, Box, or p21; however, it increased expression of p53 and 14-3-4σ, and reduced expression of Bcl-2. Celecoxib also increased the activity of caspace-3 in glioma cells. The apoptotic fraction of A172 cells induced by 24-h treatment with 100 μM celecoxib was reduced from 39% to 23% by pretreatment with caspace-3 inhibitor (DEVD-CHO) (p<0.001). Conclusion: The results suggest that celecoxib induced cytotoxicity and apoptosis in this line of glioma cells and that such effects might be related to activation of p53 and 14-3-3σ, reduced Bcl-2 and Bcl-2/Bax ratio, and increased caspace-3 activity.

Original languageEnglish
Pages (from-to)2547-2554
Number of pages8
JournalAnticancer Research
Volume27
Issue number4 B
Publication statusPublished - Jul 1 2007
Externally publishedYes

Fingerprint

Celecoxib
Glioma
Apoptosis
Mitogen-Activated Protein Kinases
Cyclooxygenase 2 Inhibitors

Keywords

  • Apoptosis
  • Celecoxib
  • Cytotoxicity
  • Glioma cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Celecoxib increased expression of 14-3-3σ and induced apoptosis of glioma cells. / Chen, Jin Cherng; Chen, Yun; Su, Yen Hao; Tseng, Sheng Hong.

In: Anticancer Research, Vol. 27, No. 4 B, 01.07.2007, p. 2547-2554.

Research output: Contribution to journalArticle

Chen, JC, Chen, Y, Su, YH & Tseng, SH 2007, 'Celecoxib increased expression of 14-3-3σ and induced apoptosis of glioma cells', Anticancer Research, vol. 27, no. 4 B, pp. 2547-2554.
Chen, Jin Cherng ; Chen, Yun ; Su, Yen Hao ; Tseng, Sheng Hong. / Celecoxib increased expression of 14-3-3σ and induced apoptosis of glioma cells. In: Anticancer Research. 2007 ; Vol. 27, No. 4 B. pp. 2547-2554.
@article{04f73309f04e41ea9e4bd78565ee8c64,
title = "Celecoxib increased expression of 14-3-3σ and induced apoptosis of glioma cells",
abstract = "Background: Celecoxib, a cyclooxygenase-2 inhibitor, has been found to inhibit the proliferation of several kinds of cancer cells; however, the effects of celecoxib on glioma cells are not clear. Materials and Methods: A172 glioma cells were treated with various concentrations of celecoxib for 4, 24 or 48 h. Cytotoxic drug effects were studied by MTT (3-[4,5-dimethylthiazole-2-yl]-2,5- diphenyltetrazolium bromide)-based colorimetric assay, and celecoxib-induced apoptosis of glioma cells was investigated by FACScan. Western blot analysis was used to study celecoxib effects on the expression of mitogen-activated protein kinases (MAPKs), p53, p21, 14-3-4σ, Bcl-2 and Box. Caspace-3 activity in glioma cells was analyzed by caspase activity assay. Results: Celecoxib exerted cytotoxic effects upon and induced apoptosis of the A172 glioma cells in a concentration and time-dependent manner (p<0.05). Celecoxib had no effects on expression of MAPKs, Box, or p21; however, it increased expression of p53 and 14-3-4σ, and reduced expression of Bcl-2. Celecoxib also increased the activity of caspace-3 in glioma cells. The apoptotic fraction of A172 cells induced by 24-h treatment with 100 μM celecoxib was reduced from 39{\%} to 23{\%} by pretreatment with caspace-3 inhibitor (DEVD-CHO) (p<0.001). Conclusion: The results suggest that celecoxib induced cytotoxicity and apoptosis in this line of glioma cells and that such effects might be related to activation of p53 and 14-3-3σ, reduced Bcl-2 and Bcl-2/Bax ratio, and increased caspace-3 activity.",
keywords = "Apoptosis, Celecoxib, Cytotoxicity, Glioma cells",
author = "Chen, {Jin Cherng} and Yun Chen and Su, {Yen Hao} and Tseng, {Sheng Hong}",
year = "2007",
month = "7",
day = "1",
language = "English",
volume = "27",
pages = "2547--2554",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 B",

}

TY - JOUR

T1 - Celecoxib increased expression of 14-3-3σ and induced apoptosis of glioma cells

AU - Chen, Jin Cherng

AU - Chen, Yun

AU - Su, Yen Hao

AU - Tseng, Sheng Hong

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Background: Celecoxib, a cyclooxygenase-2 inhibitor, has been found to inhibit the proliferation of several kinds of cancer cells; however, the effects of celecoxib on glioma cells are not clear. Materials and Methods: A172 glioma cells were treated with various concentrations of celecoxib for 4, 24 or 48 h. Cytotoxic drug effects were studied by MTT (3-[4,5-dimethylthiazole-2-yl]-2,5- diphenyltetrazolium bromide)-based colorimetric assay, and celecoxib-induced apoptosis of glioma cells was investigated by FACScan. Western blot analysis was used to study celecoxib effects on the expression of mitogen-activated protein kinases (MAPKs), p53, p21, 14-3-4σ, Bcl-2 and Box. Caspace-3 activity in glioma cells was analyzed by caspase activity assay. Results: Celecoxib exerted cytotoxic effects upon and induced apoptosis of the A172 glioma cells in a concentration and time-dependent manner (p<0.05). Celecoxib had no effects on expression of MAPKs, Box, or p21; however, it increased expression of p53 and 14-3-4σ, and reduced expression of Bcl-2. Celecoxib also increased the activity of caspace-3 in glioma cells. The apoptotic fraction of A172 cells induced by 24-h treatment with 100 μM celecoxib was reduced from 39% to 23% by pretreatment with caspace-3 inhibitor (DEVD-CHO) (p<0.001). Conclusion: The results suggest that celecoxib induced cytotoxicity and apoptosis in this line of glioma cells and that such effects might be related to activation of p53 and 14-3-3σ, reduced Bcl-2 and Bcl-2/Bax ratio, and increased caspace-3 activity.

AB - Background: Celecoxib, a cyclooxygenase-2 inhibitor, has been found to inhibit the proliferation of several kinds of cancer cells; however, the effects of celecoxib on glioma cells are not clear. Materials and Methods: A172 glioma cells were treated with various concentrations of celecoxib for 4, 24 or 48 h. Cytotoxic drug effects were studied by MTT (3-[4,5-dimethylthiazole-2-yl]-2,5- diphenyltetrazolium bromide)-based colorimetric assay, and celecoxib-induced apoptosis of glioma cells was investigated by FACScan. Western blot analysis was used to study celecoxib effects on the expression of mitogen-activated protein kinases (MAPKs), p53, p21, 14-3-4σ, Bcl-2 and Box. Caspace-3 activity in glioma cells was analyzed by caspase activity assay. Results: Celecoxib exerted cytotoxic effects upon and induced apoptosis of the A172 glioma cells in a concentration and time-dependent manner (p<0.05). Celecoxib had no effects on expression of MAPKs, Box, or p21; however, it increased expression of p53 and 14-3-4σ, and reduced expression of Bcl-2. Celecoxib also increased the activity of caspace-3 in glioma cells. The apoptotic fraction of A172 cells induced by 24-h treatment with 100 μM celecoxib was reduced from 39% to 23% by pretreatment with caspace-3 inhibitor (DEVD-CHO) (p<0.001). Conclusion: The results suggest that celecoxib induced cytotoxicity and apoptosis in this line of glioma cells and that such effects might be related to activation of p53 and 14-3-3σ, reduced Bcl-2 and Bcl-2/Bax ratio, and increased caspace-3 activity.

KW - Apoptosis

KW - Celecoxib

KW - Cytotoxicity

KW - Glioma cells

UR - http://www.scopus.com/inward/record.url?scp=34547763340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547763340&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 2547

EP - 2554

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 B

ER -